Ivanna Rosendal
Lab to Lives
A simple question started this show: How do we medicine from the lab to making a difference in people's lives as quickly as possible? The answers are complex. Actual solutions are hard to come by. We want to distill ideas until we see actual impact in the industry. Our three hosts all have backgrounds in life sciences and in improv comedy. Together, with their guests, they're on a mission to have conversations that can have an impact. And have some fun along the way.
No dejes de visitar la web del podcast y apoyar a su creador: www.labtolives.com
Autor
Ivanna Rosendal
Categoría
Web del podcast
Último episodio
18 de nov. de 2026
¿Dónde escuchar?
Podcasts en la app Replaio Radio Muy prontoLos podcasts llegarán muy pronto a la app. Instálala ahora y sé el primero en descubrir una forma totalmente nueva de vivir los podcasts
Episodios
Matt Wilson: Transforming how patients benefit from population level research 18.04.2022 50:24
Send us Fan Mail Matt Wilson guests the show and talks to Sam and Ivanna about how automating consent and recruitment processes can broaden the net in terms of the number of patients involved in clinical trials. A broader patient population means that underrepresented groups gain access to clinical trials and allow a much more detailed characterization of an overall patient population. Removing...
Ulla Sofie Lønberg and Helle Hartnack on Bias: How behavioral trials can transform access to treatment 07.04.2022 43:40
Send us Fan Mail “It is always fun to have some data that makes you go Wow! I didn’t know this!” We speak to Ulla Sofie Lønberg and Helle Hartnack about whether men are risk takers and women reluctant to experiment with health technology, and if the only difference between the male and female physiology really is the ability to bear children. We discuss the findings in a recent registry study abo...
Jakob Juul Rasmussen: Zero cost technology - transforming how smaller companies oversee their assets 31.03.2022 45:29
Send us Fan Mail Sam and Ivanna speak to Jakob Juul Rasmussen about the stubborn prevalence of paper in clinical trials, especially in small pharmaceutical and biotech companies. Paying money up front, covering the implementation and license costs and building up internal IT functions can be prohibitive for small pharmaceutical and biotech companies. This leads many companies to outsource their en...
Willie Muehlhausen: Transformation in patient reported outcomes (eCOA, ePRO and DCT) 22.03.2022 49:49
Send us Fan Mail Sam and Ivanna speak to Willie Muehlhausen about how simplifying and automating patient reported outcomes is not so much complicated, as it is complex. Willie shares his perspectives on the evolution of ePRO and eCOA and how the newer trend of decentralised clinical trials is closely tied to mastering the collection of patient reported outcomes. Willie is working towards making it...
Adam Walker: Transformation in clinical data sources 07.03.2022 43:05
Send us Fan Mail Sam and Ivanna speak Adam Walker about the transformation in clinical data from his experience with CROs, sites and sponsors. Adam takes us through how clinical data collection has evolved from paper forms, to being collected digitally and now fully integrated with patients’ existing devices. This shift increases the volume of data available, the quality of the data, but also puts...
Transformation in science, data and roles 15.02.2022 43:13
Send us Fan Mail Sam and Ivanna speak to Angela Slocum about the difficulty in quantifying the benefits of risk based monitoring when mostly you find no issues in your data. Angela does share an example of a fraudulent site being uncovered through risk based monitoring. We speak about how having experience from multiple clinical functions enables a unique platform for innovation when new demands a...
Podcasts similares
Replaio no es editor de podcasts; los nombres de los programas, las portadas y el audio pertenecen a sus autores y se distribuyen a través de canales RSS públicos